Swissmedic Grants First Authorization for Balversa® in Targeted Cancer Treatment
On October 10, 2025, Swissmedic issued its first authorization for Balversa®, marking a significant milestone in precision oncology. This pivotal…
Switzerland
Switzerland updates on medical device regulation and quality.
156 articles
156 articles in Switzerland
Europe
Europe
Swissmedic Approves Extended Use for Spevigo®: Important Regulatory Update
Swissmedic has officially approved an extension of the therapeutic indication for Spevigo®. This regulatory decision marks a refined update to…
Europe
Swissmedic Grants Initial Authorization for Voxzogo®: A Milestone for Regulatory Compliance
Swissmedic, the Swiss agency for therapeutic products, has officially granted the first authorization for Voxzogo®, marking a significant step forward…
Europe
Swissmedic Announces First Authorization for Blenrep®
Swissmedic has officially announced the first authorization of Blenrep®, marking a significant regulatory milestone in its approval process. Clinical, quality,…
Europe
Swissmedic Opens Recruitment for Financial Leadership Role in Compliance-Focused Environment
Swissmedic, Switzerland’s authority responsible for the authorization and monitoring of therapeutic products, has announced a new opportunity for experienced professionals.…
Europe
Swissmedic Opens Clinical Assessor Positions: A Vital Role in Regulatory Oversight
Swissmedic has officially announced openings for Clinical Assessors within its Division of Clinical Assessment, offering employment opportunities at an 80-100%…
Europe
Swissmedic Issues Recall for Select Batches of ASS Cardio Spirig HC 100 mg Film-Coated Tablets
On October 8, 2025, Swissmedic issued an immediate recall for specified batches of ASS Cardio Spirig HC 100 mg film-coated…
Europe
Swissmedic Updates Guidelines on Professional Advertising at Events with Patient Representatives
Swissmedic has announced a significant update regarding professional advertising practices during medical education events, particularly those attended by patient organization…
Europe
Swissmedic Advisory: Safety Update for Tegretol 2% Oral Suspension Containing Propylene Glycol
Swissmedic has issued an important safety advisory regarding Tegretol 2% oral suspension, which contains propylene glycol. This announcement highlights updated…
Europe
Swissmedic Issues Recall of Maprelin Veterinary Injection for Pigs: Key Details for Healthcare Teams
On October 7, 2025, Swissmedic announced a recall of specific batches of the veterinary medicinal product Maprelin ad us. vet.…
Europe
Swissmedic Announces Immediate Recall of Multiple Gonavet Veyx Veterinary Medicine Batches
Swissmedic has issued an urgent recall of several batches of the veterinary medicine Gonavet Veyx ad us. vet., an injectable…
Europe
Swissmedic September Journal: Key Updates for Regulatory and Quality Teams
Swissmedic, Switzerland’s authority for therapeutic products, has released its latest journal for September 2025. The publication addresses updates pivotal to…
Loading more articles…